Literature DB >> 18431667

Carvedilol: solubilization and cyclodextrin complexation: a technical note.

Thorsteinn Loftsson1, Stine Byskov Vogensen, Cyrielle Desbos, Phatsawee Jansook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18431667      PMCID： PMC2976963          DOI： 10.1208/s12249-008-9055-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN： 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  20 in total

Review 1.  Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications.

Authors:  E Redenti; L Szente; J Szejtli
Journal:  J Pharm Sci       Date:  2000-01       Impact factor: 3.534

2.  Accuracy of calculated pH-dependent aqueous drug solubility.

Authors:  Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Eur J Pharm Sci       Date:  2004-08       Impact factor: 4.384

3.  Evaluation of cyclodextrin solubilization of drugs.

Authors:  Thorsteinn Loftsson; Dagný Hreinsdóttir; Már Másson
Journal:  Int J Pharm       Date:  2005-09-30       Impact factor: 5.875

4.  General treatment of pH-solubility profiles of weak acids and bases and the effects of different acids on the solubility of a weak base.

Authors:  W H Streng; S K Hsi; P E Helms; H G Tan
Journal:  J Pharm Sci       Date:  1984-12       Impact factor: 3.534

5.  Cyclodextrins and drug permeability through semi-permeable cellophane membranes.

Authors:  Thorsteinn Loftsson; Már Másson; Hákon H Sigurdsson
Journal:  Int J Pharm       Date:  2002-01-31       Impact factor: 5.875

Review 6.  Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications.

Authors:  E Redenti; L Szente; J Szejtli
Journal:  J Pharm Sci       Date:  2001-08       Impact factor: 3.534

Review 7.  Cyclodextrin-based aggregates and characterization by microscopy.

Authors:  Yifeng He; Pei Fu; Xinghai Shen; Hongcheng Gao
Journal:  Micron       Date:  2007-07-07       Impact factor: 2.251

8.  Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.

Authors:  Xianhong Wen; Fei Tan; Zhijun Jing; Ziuyang Liu
Journal:  J Pharm Biomed Anal       Date:  2004-02-18       Impact factor: 3.935

9.  The effects of organic salts on the cyclodextrin solubilization of drugs.

Authors:  Thorsteinn Loftsson; Kristján Matthíasson; Már Másson
Journal:  Int J Pharm       Date:  2003-08-27       Impact factor: 5.875

Review 10.  Self-association of cyclodextrins and cyclodextrin complexes.

Authors:  Thorsteinn Loftsson; Már Másson; Marcus E Brewster
Journal:  J Pharm Sci       Date:  2004-05       Impact factor: 3.534
View more
  10 in total

Review 1.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

3.  pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.

Authors:  Rania Hamed; Areeg Awadallah; Suhair Sunoqrot; Ola Tarawneh; Sami Nazzal; Tamadur AlBaraghthi; Jihan Al Sayyad; Aiman Abbas
Journal:  AAPS PharmSciTech       Date:  2015-07-23       Impact factor: 3.246

4.  Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media.

Authors:  Duygu Yilmaz Usta; Tuba Incecayir
Journal:  AAPS PharmSciTech       Date:  2022-07-26       Impact factor: 4.026

5.  Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin.

Authors:  Rohan V Karanje; Yogita V Bhavsar; Kirti H Jahagirdar; Kiran S Bhise
Journal:  AAPS PharmSciTech       Date:  2013-03-21       Impact factor: 3.246

6.  The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays.

Authors:  Francesco Tres; Maria M Posada; Stephen D Hall; Michael A Mohutsky; Lynne S Taylor
Journal:  Pharm Res       Date:  2019-10-25       Impact factor: 4.200

7.  Preparation and characterization of solid dispersions of carvedilol with PVP K30.

Authors:  A Sharma; C P Jain
Journal:  Res Pharm Sci       Date:  2010-01

8.  Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design.

Authors:  Zhou Zhou; Claire Dunn; Ibrahim Khadra; Clive G Wilson; Gavin W Halbert
Journal:  Mol Pharm       Date:  2017-08-22       Impact factor: 4.939

9.  Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents.

Authors:  Ayesha Zafar; Lisa I Pilkington; Natalie A Haverkate; Michelle van Rensburg; Euphemia Leung; Sisira Kumara; William A Denny; David Barker; Ali Alsuraifi; Clare Hoskins; Jóhannes Reynisson
Journal:  Molecules       Date:  2018-01-11       Impact factor: 4.411

10.  Development and validation of new discriminative dissolution method for carvedilol tablets.

Authors:  V Raju; K V R Murthy
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.